1. Apoptosis
  2. Apoptosis
  3. (Gly14)-Humanin (human)

(Gly14)-Humanin (human)  (Synonyms: 14-Glycine-Humanin (human))

目录号: HY-P3993
产品使用指南

(Gly14)-Humanin (human) (14-Glycine-Humanin (human)) 是 Humanin 的类似物,其中第 14 个氨基酸丝氨酸被甘氨酸 (Gly) 取代。(Gly14)-Humanin (human) 具有抗细胞凋亡和神经保护功能。

MCE 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务

Custom Peptide Synthesis

(Gly14)-Humanin (human) Chemical Structure

(Gly14)-Humanin (human) Chemical Structure

CAS No. : 330936-70-4

1.  客户无需承担相应的运输费用。

2.  同一机构(单位)同一产品试用装仅限申领一次,同一机构(单位)一年内

     可免费申领三个不同产品的试用装。

3.  试用装只面向终端客户

规格 是否有货
50 mg   询价  
100 mg   询价  
250 mg   询价  

* Please select Quantity before adding items.

(Gly14)-Humanin (human) 的其他形式现货产品:

Customer Review

Other Forms of (Gly14)-Humanin (human):

注册 MCE会员完成审核
即刻享有 积分商城 300 专属积分

Top Publications Citing Use of Products
  • 生物活性

  • 纯度 & 产品资料

  • 参考文献

生物活性

(Gly14)-Humanin (human) (14-Glycine-Humanin (human)) is an analog of Humanin in which the 14th amino acid serine was replaced with glycine (Gly). (Gly14)-Humanin (human) has anti-apoptotic and neuroprotective functions[1][2].

体外研究
(In Vitro)

(Gly14)-Humanin (human) (0.1-10 μM; 72 hours) 显着增加细胞活力,降低 HUVEC 的核荧光、裂解 PARP 水平、ROS 形成和 bax/bcl-2 比值 。并降低 bax 的mRNA水平,增加 bcl-2 的 mRNA 水平[1]

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Cell Viability Assay[1]

Cell Line: Human umbilical vein endothelial cells (HUVECs)
Concentration: 100 nM, 1 μM and 10 μM
Incubation Time: Pretreatment 3 hours and then treated with 72 hours
Result: Significantly increased cell viability.

Western Blot Analysis[1]

Cell Line: Human umbilical vein endothelial cells (HUVECs)
Concentration: 1 μM
Incubation Time: Pretreatment 3 hours and then treated with 72 hours
Result: Reduced the ratio of bax/bcl-2.
体内研究
(In Vivo)

(Gly14)-Humanin (human)(0.1 μg/5 μL;i.c.v.;一次)减少受损皮层和海马体中具有质膜通透性的细胞,减少脑损伤体积,改善运动性能并改善莫里斯水迷宫试验中的性能[2]

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: Adult male CD-1 mice (25-30 g; 10-12-week-old) bearing traumatic brain injury (TBI)[2]
Dosage: 0.1 μg/5 μL
Administration: Intracerebroventricularly (i.c.v.); once
Result: Decreased cells with plasmalemma permeability in the injured cortex and hippocampus, reduced brain lesion volume, improved motor performance.
分子量

2657.21

Formula

C118H202N34O31S2

CAS 号
Sequence Shortening

MAPRGFSCLLLLTGEIDLPVKRRA

运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.

纯度 & 产品资料
参考文献

(Gly14)-Humanin (human) 相关分类

  • 摩尔计算器

  • 稀释计算器

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

质量   浓度   体积   分子量 *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

浓度 (start) × 体积 (start) = 浓度 (final) × 体积 (final)
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

您最近查看的产品:

Your information is safe with us. * Required Fields.

   产品名称:

 

* 需求量:

* 客户姓名:

 

* Email:

* 电话:

 

* 公司或机构名称:

   留言给我们:

Bulk Inquiry

Inquiry Information

产品名称:
(Gly14)-Humanin (human)
目录号:
HY-P3993
需求量: